U.S. Seizes Batches of Two Glaxo Drugs Over Quality Friday March 4, 11:33 AM EST WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Friday that officials had seized batches of GlaxoSmithKline Plc's (GSK) diabetes drug Avandamet and the controlled-release antidepressant Paxil CR because of concerns over manufacturing quality. The FDA said in a statement that the manufacturing practices for the two drugs failed to meet standards for safety, strength, quality and purity. However, the agency said it was not aware of any harm to consumers and did not believe there was a significant health hazard. Patients taking...